These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23913402)

  • 1. Advanced cancer risk similar with biennial vs. annual mammography in women aged 50 to 74.
    Printz C
    Cancer; 2013 Aug; 119(16):2949. PubMed ID: 23913402
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
    Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
    Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective biennial mammographic screening in women aged 40-49.
    van Schoor G; Moss SM; Otten JD; Donders R; Paap E; den Heeten GJ; Holland R; Broeders MJ; Verbeek AL
    Eur J Cancer; 2010 Dec; 46(18):3137-40. PubMed ID: 21036034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.
    Klarenbach S; Sims-Jones N; Lewin G; Singh H; Thériault G; Tonelli M; Doull M; Courage S; Garcia AJ; Thombs BD;
    CMAJ; 2018 Dec; 190(49):E1441-E1451. PubMed ID: 30530611
    [No Abstract]   [Full Text] [Related]  

  • 5. Uruguay's mandatory breast cancer screening for working women aged 40-59 is challenged.
    Arie S
    BMJ; 2013 Mar; 346():f1907. PubMed ID: 23518383
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer screening with mammography.
    Hirsch BR; Lyman GH
    Curr Oncol Rep; 2011 Feb; 13(1):63-70. PubMed ID: 21108025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer detection risk in screening mammography after a false-positive result.
    Castells X; Román M; Romero A; Blanch J; Zubizarreta R; Ascunce N; Salas D; Burón A; Sala M;
    Cancer Epidemiol; 2013 Feb; 37(1):85-90. PubMed ID: 23142338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit.
    Maurice A; Evans DG; Affen J; Greenhalgh R; Duffy SW; Howell A
    Int J Cancer; 2012 Jul; 131(2):417-25. PubMed ID: 21898384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast density legislation fueling controversy.
    Brower V
    J Natl Cancer Inst; 2013 Apr; 105(8):510-1. PubMed ID: 23524285
    [No Abstract]   [Full Text] [Related]  

  • 11. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
    Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
    Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast cancer screening imaging: what do we do].
    Balu-Maestro C; Chapellier C; Souci J; Caramella T; Marcotte-Bloch C
    J Gynecol Obstet Biol Reprod (Paris); 2010 Feb; 39(1):3-10. PubMed ID: 19850418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding 3D imaging to mammography improves breast cancer detection.
    Mayor S
    BMJ; 2014 Jun; 348():g4248. PubMed ID: 24964877
    [No Abstract]   [Full Text] [Related]  

  • 15. The association between the pre-diagnosis mammography screening interval and advanced breast cancer.
    Goel A; Littenberg B; Burack RC
    Breast Cancer Res Treat; 2007 May; 102(3):339-45. PubMed ID: 16927175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.
    Hendrick RE; Helvie MA
    AJR Am J Roentgenol; 2012 Mar; 198(3):723-8. PubMed ID: 22358016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations.
    Hunt KA; Rosen EL; Sickles EA
    AJR Am J Roentgenol; 1999 Aug; 173(2):285-9. PubMed ID: 10430120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia.
    Randall D; Morrell S; Taylor R; Hung WT
    Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy.
    de Gelder R; Heijnsdijk EA; Fracheboud J; Draisma G; de Koning HJ
    Int J Cancer; 2015 Jul; 137(1):165-72. PubMed ID: 25430053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.